Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting

Data on the association between chimeric antigen receptor (CAR)-T-cell kinetics and patient outcome in the nontrial setting are missing, mainly due to the lack of broadly available CAR-T-cell diagnostic quantification tools. We performed prospective quantification of axicabtagene ciloleucel (axi-cel...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood Adv
Prif Awduron: Ayuk, Francis A., Berger, Carolina, Badbaran, Anita, Zabelina, Tatjana, Sonntag, Tanja, Riecken, Kristoffer, Geffken, Maria, Wichmann, Dominic, Frenzel, Christian, Thayssen, Guenther, Zeschke, Silke, Kröger, Nicolaus, Fehse, Boris
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2021
Pynciau:
Stimulus Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238487/
https://ncbi.nlm.nih.gov/pubmed/34100900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003959
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg